Fourth branchial anomalies: Predictive factors of therapeutic success.


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 18 05 2018
revised: 12 02 2019
accepted: 13 02 2019
pubmed: 15 4 2019
medline: 4 12 2019
entrez: 15 4 2019
Statut: ppublish

Résumé

The purpose of this work was to determine the epidemiology and the predictive factors of success of the surgical management of fourth branchial anomalies. This is a multicentric retrospective review from 1998 to 2016 of patients who presented with an endoscopically-confirmed fourth branchial pouch anomaly. Data were analyzed according to sex, age, clinical features, number of recurrences, treatment modalities (endoscopic and/or cervicotomy), post-operative complications and follow-up. Fifty-two children have been included. The average age at diagnosis was 4.5 years. Among them, 73.1% were female, 11.4% were neonatal forms; 94.2% of lesions were left-sided; 75% of patients presented a cervical abscess as first symptom, and 7.7% of children presented with dyspnea. Average time between first symptoms and management was 9.5 months. Management was endoscopic in 73.1% of patients (laser in 84.2%, coagulation in 15.8%) with about a third of recurrence after one procedure. Overall success of endoscopic procedures reached 84.2%. A cervical open surgery was performed in 26.9% as first line treatment. Overall success of cervicotomy reached 85.7%. No complications of endoscopic surgery have been identified. There were 35.7% complications of cervicotomy (2 recurrent nerve palsy, 2 keloid scars, 1 pharyngostoma). An association was proved between recurrences and initial abscess (OR = 2.44), and with age between 3 and 5 (OR = 4). Endoscopic treatments appear to be effective in first line approach in the management of fourth branchial anomalies, offering an excellent efficiency with rare complications. We identified two risk factors of recurrence: age between 3 and 5 years old and history of cervical abscesses. IV.

Identifiants

pubmed: 30981424
pii: S0022-3468(19)30111-3
doi: 10.1016/j.jpedsurg.2019.02.005
pii:
doi:

Types de publication

Journal Article Multicenter Study Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1702-1707

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Marie-Eva Rossi (ME)

ENT department, Hôpital d'enfants La Timone, Assistance Publique - Hôpitaux de Marseille, Aix-Marseille Université, Marseille, France. Electronic address: marie-eva.ROSSI@ap-hm.fr.

Eric Moreddu (E)

ENT department, Hôpital d'enfants La Timone, Assistance Publique - Hôpitaux de Marseille, Aix-Marseille Université, Marseille, France.

Nicolas Leboulanger (N)

ENT department, Hôpital d'enfants Necker, Assistance Publique - Hôpitaux de Paris, Paris V Université, Marseille, France.

Mohamed Akkari (M)

ENT department, Hôpital Gui de Chauliac, Assistance Publique - Hôpitaux de Montpellier, Montpellier Université, Montpellier, France.

Jean-Michel Triglia (JM)

ENT department, Hôpital d'enfants La Timone, Assistance Publique - Hôpitaux de Marseille, Aix-Marseille Université, Marseille, France.

Michel Mondain (M)

ENT department, Hôpital Gui de Chauliac, Assistance Publique - Hôpitaux de Montpellier, Montpellier Université, Montpellier, France.

Richard Nicollas (R)

ENT department, Hôpital d'enfants La Timone, Assistance Publique - Hôpitaux de Marseille, Aix-Marseille Université, Marseille, France.

Françoise Denoyelle (F)

ENT department, Hôpital d'enfants Necker, Assistance Publique - Hôpitaux de Paris, Paris V Université, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH